Minimum System Requirements | Privacy Policy | Contact Us
CME Credit Statement -- This activity has been reviewed and is acceptable for up to 1.0 Prescribed credit.
Learning Objectives -- Learning objectives for the "Osteoporosis: An Online Plenary Session From the 2008 Scientific Assembly" presentation.
Osteoporosis: An Online Plenary Session from the 2008 Scientific Assembly
Summary
This online plenary from the 2008 Scientific Assembly exemplifies the AAFP's 2009 Annual Clinical Focus on the Management of Chronic Illness. Listen to the lecture and follow along with the slides. Submit the post-test for CME credit, free to AAFP members.
Author Information
Stuart Silverman, MD, FACP, FACR, is an attending rheumatologist in the Division of Rheumatology at Cedars-Sinai Medical Center, Los Angeles, CA. He is a clinical professor of medicine and rheumatology at the David Geffen School of Medicine at UCLA.
Dr Silverman is known internationally for his work in fibromyalgia and osteoporosis. He is currently a member of the Scientific Advisory Council of the National Osteoporosis Foundation, and an American Society for Bone and Mineral Research representative to the Interspecialty Medical Council of the foundation. Dr Silverman serves on the Council of Scientific Advisors of the International Osteoporosis Foundation.
Disclosure Statement: Dr. Silverman reported that he has received research grants from Roche, Lilly, Procter & Gamble and Novartis; received manuscript assistance from Wyeth, is a speaker for Roche, Lilly, Procter & Gamble and Novartis; and is on the advisory board of Roche, Lilly, Procter & Gamble and Novartis. Any potential conflict of interest was resolved through the peer-review process.
Dr Silverman is known internationally for his work in fibromyalgia and osteoporosis. He is currently a member of the Scientific Advisory Council of the National Osteoporosis Foundation, and an American Society for Bone and Mineral Research representative to the Interspecialty Medical Council of the foundation. Dr Silverman serves on the Council of Scientific Advisors of the International Osteoporosis Foundation.
Disclosure Statement: Dr. Silverman reported that he has received research grants from Roche, Lilly, Procter & Gamble and Novartis; received manuscript assistance from Wyeth, is a speaker for Roche, Lilly, Procter & Gamble and Novartis; and is on the advisory board of Roche, Lilly, Procter & Gamble and Novartis. Any potential conflict of interest was resolved through the peer-review process.
Disclaimer
The views and opinions expressed herein are those of the faculty and do not necessarily represent those of the American Academy of Family Physicians and Roche.
It is the policy of the American Academy of Family Physicians that all CME planning committee/faculty/authors/editors/staff disclose their relationships with commercial entities upon nomination/invitation of participation. Disclosure documents are reviewed for potential conflicts of interest and, if identified, they are resolved prior to confirmation of participation. Only those participants who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this CME activity.
The AAFP uses an anonymous peer review process to evaluate the content of CME activities. This process ensures a clear identification and resolution of any potential conflicts of interest, and guarantees the fairness and balance of the content.
It is the policy of the American Academy of Family Physicians that all CME planning committee/faculty/authors/editors/staff disclose their relationships with commercial entities upon nomination/invitation of participation. Disclosure documents are reviewed for potential conflicts of interest and, if identified, they are resolved prior to confirmation of participation. Only those participants who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this CME activity.
The AAFP uses an anonymous peer review process to evaluate the content of CME activities. This process ensures a clear identification and resolution of any potential conflicts of interest, and guarantees the fairness and balance of the content.
This CME activity is supported in part by an educational grant to the AAFP from Roche.
View the Emerging Strategies in Diagnosis and Treatment of Osteoporosis Presentation -- Flash Player 8 is required.
(43:56-minute Flash file. About Flash)
(43:56-minute Flash file. About Flash)
Osteoporosis Online Plenary Session
